AGI-14100

• Description:

  AGI-14100 is a novel and orally available mIDH1 inhibitor.AGI-14100 is used for the treatment of primary human myeloid leukemia.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  599.96

• Molecular Formula:

  C29H22ClF4N5O3

• Notes:

  Research use only, not for human use.

• Receptor:

  Dehydrogenase

• CAS Number:

  1448346-43-7